Re: Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities. S. E. Eggener, P. T. Scardino, P. R. Carroll, M. J. Zelefsky, O. Sartor, H. Hricak, T. M. Wheeler, S. W. Fine, J. Trachtenberg, M. A. Rubin, M. Ohori, K. Kuroiwa, M. Rossignol and L. Abenhaim, International Task Force on Prostate Cancer and the Focal Lesion Paradigm J Urol 2007; 178: 2260-2267

Journal of Urology

Volumn 180, Issue 2, 2008, Pages 780-783

  Ahmed, Hashim Uddin ^a   Emberton, Mark ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM BACTERIOPHEOPHORBIDE;

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER THERAPY; CRYOABLATION; CRYOSURGERY; DOPPLER FLOWMETRY; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMPOTENCE; LETTER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIOFREQUENCY ABLATION;

ANDROGEN ANTAGONISTS; CRYOSURGERY; DECISION MAKING; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT SELECTION; PHOTOCHEMOTHERAPY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 46449093285     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.04.045     Document Type: Letter

References (20)

1. Ahmed H.U., Pendse D., Illing R., Allen C., van der Meulen J.H., and Emberton M. Will focal therapy become a standard of care for men with localized prostate cancer?. Nat Clin Pract Oncol 4 (2007) 632
2. Onik G: Focal cryoablation for prostate cancer. Presented at annual meeting of Society of Interventional Radiology. New Orleans, Louisiana, March 31-April 4, 2005.
3. Bahn D.K., Silverman P., Lee Sr. F., Badalament R., Bahn E.D., and Rewcastle J.C. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 20 (2006) 688
4. Harlan S.R., Cooperberg M.R., Elkin E.P., Lubeck D.P., Meng M.V., Mehta S.S., et al. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol 170 (2003) 1804
5. Krupski T.L., Kwan L., Afifi A.A., and Litwin M.S. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 23 (2005) 7881
6. Carter H.B., Kettermann A., Warlick C., Metter E.J., Landis P., Walsh P.C., et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 178 (2007) 2359
7. Van As NJ, Norman AR, Woode-Amissah R, Horwich A, Dearnaley DP, Huddart RA et al: Active surveillance of low risk localized prostate cancer: baseline predictors of disease progression. Presented at Prostate Cancer Symposium, American Society of Clinical Oncology, Orlando, Florida, May 22-24, 2007.
8. Klotz L. Active surveillance for prostate cancer: for whom?. J Clin Oncol 23 (2005) 8165
9. Soloway M.S., Soloway C.T., Williams S., Ayyathurai R., Kava B., and Manoharan M. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 101 (2008) 165
10. Venkitaraman R., Norman A., Woode-Amissah R., Fisher C., Dearnaley D., Horwich A., et al. Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 178 (2007) 833
11. Cooperberg M.R., Lubeck D.P., Meng M.V., Mehta S.S., and Carroll P.R. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141
12. Crawford E.D., Wilson S.S., Torkko K.C., Hirano D., Stewart J.S., Brammell C., et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int 96 (2005) 999
13. Furuno T., Demura T., Kaneta T., Gotoda H., Muraoka S., Sato T., et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 58 (2004) 76
14. Onik G. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Cardiovasc Intervent Radiol 31 (2008) 98
15. Cooperberg M.R., Moul J.W., and Carroll P.R. The changing face of prostate cancer. J Clin Oncol 23 (2005) 8146
16. Miller D.C., Gruber S.B., Hollenbeck B.K., Montie J.E., and Wei J.T. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst 98 (2006) 1134
17. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D., Sanders M.M., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 (2005) 1248
18. Cuzick J., Fisher G., Kattan M.W., Berney D., Oliver T., Foster C.S., et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 95 (2006) 1186
19. Johansson J.E., Andren O., Andersson S.O., Dickman P.W., Holmberg L., Magnuson A., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713
20. Hull G.W., Rabbani F., Abbas F., Wheeler T.M., Kattan M.W., and Scardino P.T. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528